DK3452050T3 - Composition comprising hmos for the treatment of noninfectious diarrhoea - Google Patents

Composition comprising hmos for the treatment of noninfectious diarrhoea Download PDF

Info

Publication number
DK3452050T3
DK3452050T3 DK17792540.1T DK17792540T DK3452050T3 DK 3452050 T3 DK3452050 T3 DK 3452050T3 DK 17792540 T DK17792540 T DK 17792540T DK 3452050 T3 DK3452050 T3 DK 3452050T3
Authority
DK
Denmark
Prior art keywords
hmos
noninfectious
diarrhoea
treatment
composition
Prior art date
Application number
DK17792540.1T
Other languages
English (en)
Inventor
Emma Elison
Bruce Mcconnell
Louise Kristine Vigsnaes
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=60202765&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3452050(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US15/147,112 external-priority patent/US20160243138A1/en
Application filed by Glycom As filed Critical Glycom As
Application granted granted Critical
Publication of DK3452050T3 publication Critical patent/DK3452050T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK17792540.1T 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of noninfectious diarrhoea DK3452050T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/147,112 US20160243138A1 (en) 2014-10-29 2016-05-05 Composition comprising HMSs/HMOs and use thereof
PCT/DK2017/050145 WO2017190754A1 (en) 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of non-infectious diarrhoea

Publications (1)

Publication Number Publication Date
DK3452050T3 true DK3452050T3 (da) 2023-02-20

Family

ID=60202765

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17792540.1T DK3452050T3 (da) 2016-05-05 2017-05-05 Composition comprising hmos for the treatment of noninfectious diarrhoea

Country Status (5)

Country Link
EP (1) EP3452050B1 (da)
DK (1) DK3452050T3 (da)
ES (1) ES2938355T3 (da)
PL (1) PL3452050T3 (da)
WO (1) WO2017190754A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
WO2017190754A1 (en) 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea
JP7327724B2 (ja) 2017-11-30 2023-08-16 グリコム・アクティーゼルスカブ 小麦過敏症を処置するためのｈｍｏの混合物
US20210239696A1 (en) * 2018-05-09 2021-08-05 Carbiotix Ab Method for measuring and improving gut health
WO2020128947A1 (en) * 2018-12-19 2020-06-25 Glycom A/S Composition and method for treating humans using low-fodmap diets
WO2020174386A1 (en) 2019-02-25 2020-09-03 Nutribam Bvba Composition, food supplement and method for supporting and/or improving intestinal health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
EP4065127A4 (en) * 2019-11-27 2024-01-03 Glycom As HMO BLEND
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
CN117286078B (zh) * 2023-11-21 2024-02-02 四川厌氧生物科技有限责任公司 一种改善胃肠道健康的植物乳植杆菌及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
EP1991690B1 (en) 2006-03-09 2014-01-15 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
CN102341948B (zh) 2009-03-05 2014-04-16 日产自动车株式会社 双极型二次电池及其生产方法
EP2417144B1 (en) 2009-04-07 2017-08-23 Glycom A/S Synthesis of 2'-o-fucosyllactose
EP2536737B1 (en) 2010-02-19 2017-05-31 Glycom A/S A method for preparation of the tetrasaccharide lacto-n-neotetraose (lnnt) containing n-acetyllactosamine
US20130172548A1 (en) 2010-07-16 2013-07-04 Glycom A/S, Kgs. Derivatization of oligosaccharides
CN103763940B (zh) * 2010-12-31 2015-10-14 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
CA2822500C (en) * 2010-12-31 2022-07-26 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
US20140046044A1 (en) 2011-02-21 2014-02-13 Glycom A/S Novel glycosyl phosphites
US20140228554A1 (en) 2011-03-18 2014-08-14 Glycom A/S Synthesis of new fucose-containing carbohydrate derivatives
AU2012257395A1 (en) 2011-05-13 2013-12-12 Glycom A/S Method for generating human milk oligosaccharides (HMOs) or precursors thereof
US20140323705A1 (en) 2011-05-13 2014-10-30 Markus Hederos Manufacture of lacto-n-tetraose
PL2707380T3 (pl) 2011-05-13 2021-01-11 Glycom A/S Dywersyfikacja oligosacharydów mleka kobiecego (hmo) lub ich prekursorów
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
CN103958537A (zh) 2011-09-30 2014-07-30 格礼卡姆股份公司 Hmo核心结构的合成
WO2013091660A1 (en) 2011-12-23 2013-06-27 Glycom A/S A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
EP2828275B1 (en) 2012-03-20 2017-03-01 Glycom A/S Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
US20150265661A1 (en) * 2012-04-13 2015-09-24 Trustees Of Boston College Prebiotic effect of sialyllactose
EP2842560A4 (en) * 2012-04-23 2015-12-02 Univ Kyoto COMPOSITION FOR PROMOTING BIFIDOBACTERIUM GROWTH
CN105722514A (zh) 2013-11-15 2016-06-29 雀巢产品技术援助有限公司 用于预防或治疗剖腹产婴儿或幼儿的坏死性小肠结肠炎的组合物
US10695358B2 (en) * 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
EP3125905A4 (en) 2014-04-04 2017-11-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
EP3673909A1 (en) * 2014-04-08 2020-07-01 Abbott Laboratories Nutritional compositions for use in treating enteric infection comprising human milk oligosaccharides
WO2016066175A1 (en) * 2014-10-29 2016-05-06 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2017084673A1 (en) * 2015-11-17 2017-05-26 Glycom A/S Synthetic Composition for Treating Antibiotic Associated Complications
WO2017190754A1 (en) 2016-05-05 2017-11-09 Glycom A/S Composition comprising hmos for the treatment of non-infectious diarrhoea

Also Published As

Publication number Publication date
EP3452050B1 (en) 2022-11-23
EP3452050A4 (en) 2020-01-08
EP3452050A1 (en) 2019-03-13
ES2938355T3 (es) 2023-04-10
PL3452050T3 (pl) 2023-06-12
WO2017190754A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
DK3452050T3 (da) Composition comprising hmos for the treatment of noninfectious diarrhoea
IL253945B (en) kdm1a inhibitors to treat the disease
MA44702A (fr) Compositions de suspension à libération prolongée
DK3466432T3 (da) Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
BR112016021682A2 (pt) cenicriviroc para o tratamento da fibrose
DK3474804T4 (da) Medicinsk forbinding
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3524255T3 (da) Sammensætning til behandling af acne
BR112016022976A2 (pt) Métodos para o tratamento de hcv
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
DK3307267T3 (da) Behandling af multipel sklerose
KR20180084853A (ko) 지혈 조성물
DK3261661T3 (da) Menotropin til behandling af infertilitet
DK3373931T3 (da) Heterocykliske forbindelser til behandling af sygdom
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
BR112016024667A2 (pt) composições de revestimento melhorado e processos para fabricação das mesmas
IT201600121617A1 (it) Composizione per il trattamento del reflusso gastroesofageo
DK3294769T3 (da) Behandling for multipelt myelom (mm)
DK3096775T3 (da) SOCS-mimetika til behandling af sygdomme
DK3484475T3 (da) 1-methylnicotinamid til behandlingen af kardiovaskulær sygdom
DK3352735T3 (da) Olanzapinformuleringer med langvarig frigivelse
KR20180084983A (ko) 암의 치료를 위한 피리미도-피리미다지논의 용도
DK3331610T3 (da) Midler til anvendelse til behandling af gliom
DK3149163T3 (da) Prohæmostatiske proteiner til behandling af blødning